Get started
MarketMoversReport

Cara Therapeutics Announces Positive Topline Results

Long
Cara Therapeutics, Inc. (NASDAQ:CARA)  
MarketMoversReport  
NASDAQ:CARA   Cara Therapeutics, Inc.
Beyond Technical Analysis
1
1
beyondta
CARA: Cara Therapeutics, Inc.
2022-06-30 07:00:00
Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Nostalgia Paresthetica
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.